Physician profile
Soe Win
NPI 1205094315
$1,296.55
in general payments reported to CMS, 2019-2025
10 companies · $64.81 in 2025
The $64.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $99.12 · 2021: $118 · 2022: $341 · 2023: $201 · 2024: $189 · 2025: $64.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $300.82 | 2019-2024 | Andexxa, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $252.02 | 2019-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $233.87 | 2019-2024 | Xarelto |
| Abbvie INC. | $181.07 | 2022-2025 | Teflaro |
| Melinta Therapeutics, LLC | $129.37 | 2019-2022 | |
| Allergan, INC. | $77.89 | 2019-2020 | |
| Novo Nordisk INC | $55.04 | 2024-2025 | Novoseven, Novoeight |
| Pfizer INC. | $25.80 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.44 | 2020 | |
| Amarin Pharma, INC. | $15.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soe Win listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.